Radiation
68Ga-PSMA-617
68Ga-PSMA-617 is a radiation therapy with 4 clinical trials. Currently 1 active trials ongoing.
Total Trials
4
Max Phase
—
Type
RADIATION
Molecule
—
Success Metrics
Active Trials
1(25%)
Phase Distribution
Ph phase_2
2
50%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Other(2)
Detailed Status
unknown2
Not yet recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 22 (66.7%)
N/A1 (33.3%)
Trials by Status
not_yet_recruiting125%
recruiting125%
unknown250%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable
68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors
NCT07639801
recruiting
68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study
NCT05228106
unknownphase_2
Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients
NCT05841992
unknownphase_2
68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients
NCT04796467
Clinical Trials (4)
Showing 4 of 4 trials
NCT07639801Not Applicable
68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors
NCT05228106
68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study
NCT05841992Phase 2
Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients
NCT04796467Phase 2
68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients
All 4 trials loaded
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 4